Explore our product offering by market:
We are a world leader in pharmaceutical excipients, vaccine adjuvants and lipid delivery systems for human and veterinary applications.
Human pharmaceuticals
We specialise in developing the highest quality and purest grades of pharmaceutical excipients, lipids and vaccine adjuvants to help you formulate seamlessly and drive your products to market. We tailor excipient purity to your needs. We are committed to product quality, regulatory excellence, and supply chain security. We have worked with many pharma companies to bring COVID-19 vaccines and treatments to market faster, using our adjuvant and Super Refined™ excipients. While continuing to invest in expanding our portfolio and manufacturing footprint globally, quality is at the forefront of our plans.
Veterinary health
To serve the growing veterinary health market, we develop and commercialise a wide range of specialty excipients which are used to enhance the delivery, efficacy, and stability of actives in livestock and companion animal health products. Our broad portfolio also comprises adjuvants for the important veterinary vaccine market and extends further to omega-3 essential fatty acids for pet food products. We collaborate with your formulation scientists to produce safer, more efficient, and highly specialised products that are used across a variety of marketed veterinary dosage forms. We strive to offer innovative solutions to meet the challenges formulators, veterinarians and livestock producers face every day.
Explore recent blogs:
Announcing Avanti Research - a Croda brand
Avanti Polar Lipids, a global leader in lipids, has announced its renewed offering for researchers and its transformation to Avanti Research.
EXCLUSIVE WHITEPAPER: Next-generation Triton™ X-100 replacements for pharmaceutical bioprocessing
Triton™ X-100 (tert-octyl phenyl ethoxylate) is used extensively in the manufacture of biologics, plasma-derived products and cell and gene therapies (CGTs). This non-ionic detergent is used because...
Veterinary vaccines - solutions for an ongoing challenge...
Growth in the veterinary pharmaceutical industry continues to be driven by increasing pet ownership globally and the rising demand for veterinary vaccines to prevent the risk of zoonotic diseases in...